In the final hours of Oklahoma’s legislative session late last night, lawmakers overwhelmingly voted to override Gov. Kevin Stitt’s (R) [...] …
Category: Pharma Industry
The first published decision under the revamped 340B Administrative Dispute Resolution (ADR) process sided with the drug industry, marking a [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Novartis and Bristol Myers Squibb (BMS) are both asking a federal appeals court to overturn a lower court’s ruling that [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Tennessee covered entities must now submit claims data for all Boehringer Ingelheim (BI) 340B drugs filled by their in-house pharmacies [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Three drugmakers will refund covered entities that purchased certain 340B-priced medications following recent adjustments to their 340B drug ceiling prices. [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Oregon state senators late yesterday narrowly passed legislation to prohibit drugmakers from restricting 340B contract pharmacy access in the state. [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Oregon state senators are pushing for competing amendments to a 340B contract pharmacy access bill that passed the state House; [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
AstraZeneca and the brand-name drug industry’s leading trade group have filed federal lawsuits challenging newly enacted 340B contract pharmacy access [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two Oklahoma Republican lawmakers are urging their colleagues to override Gov. Kevin Stitt’s (R) veto of a 340B contract pharmacy [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Following a string of losses in federal courts, some drugmakers are now turning to state-level courts in an effort to [...] …